ncRNA name
LINC00261
Specific or universal ncRNAs
Specific ncRNAs
Class
Long noncoding RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
miR-545-3p/MT1M
Cancer name
Esophageal Squamous Cell Carcinoma
Cancer site
qRT-PCR,Western blot,Luciferase assay
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Down
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Down
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
LINC00261 Suppresses Cisplatin Resistance of Esophageal Squamous Cell Carcinoma Through miR-545-3p/MT1M Axis
Tissue resource
paired esophageal squamous cell carcinoma tumor tissues and adjacent non-tumor tissues
esophageal squamous cell carcinoma cell lines TE-1
esophageal squamous cell carcinoma cell lines ECA109
Experiment
None
Institute
Jiangsu Cancer Hospital
the Chinese Academy of Sciences cell bank
Country
China
China
Continent
Asia
Asia